Go Pro
→ Now that SpaceX is public, buy this ticker (no, not SpaceX or Tesla) (From Brownstone Research) (Ad)tc pixel Free PPH Stock Alerts

VanEck Pharmaceutical ETF (PPH) Short Interest Ratio & Short Volume

VanEck Pharmaceutical ETF logo
$110.83 -0.69 (-0.62%)
As of 01:57 PM Eastern
Compare

VanEck Pharmaceutical ETF Short Interest Overview

As of July 31, 2026, VanEck Pharmaceutical ETF (PPH) had a short interest of 2.64 million shares sold short, representing 31.24% of the public float. This marks a -6.99% decrease in short interest since the prior report. The short interest ratio (days to cover) is 12.1, meaning it would take 12.1 days of the average trading volume of 317,116 shares to cover all short positions.

Current Short Interest
2,636,544 shares
Previous Short Interest
2,834,538 shares
Change Vs. Previous Month
-6.99%
Dollar Volume Sold Short
$291.07 million
Short Interest Ratio
12.1 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
8,440,000 shares
Short Percent of Float
31.24%
Today's Trading Volume
125,390 shares
Average Trading Volume
317,116 shares
Today's Volume Vs. Average
40%
Short Selling VanEck Pharmaceutical ETF?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

PPH Short Interest Over Time

PPH Days to Cover Over Time

PPH Percentage of Float Shorted Over Time

VanEck Pharmaceutical ETF Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20262,636,544 shares $291.07 million -7.0%31.2%12.12 $110.40
7/15/20262,834,538 shares $304.83 million +4.6%33.2%10.92 $107.54
6/30/20262,710,078 shares $296.35 million +43.5%31.0%8.12 $109.35
6/15/20261,888,151 shares $198.94 million +56.0%19.9%6.21 $105.36
5/29/20261,210,333 shares $126.77 million -0.5%12.8%6.8 $104.74
5/15/20261,216,742 shares $122.70 million -16.8%12.8%8.1 $100.84
4/30/20261,462,498 shares $148.96 million -1.6%15.4%8.03 $101.85
4/15/20261,486,734 shares $153.64 million -6.2%15.7%9.94 $103.34
3/31/20261,584,373 shares $164.58 million -34.6%18.2%2.84 $103.88
3/13/20262,421,516 shares $252.71 million -8.9%21.9%6.56 $104.36
2/27/20262,658,824 shares $296.99 million -10.4%24.1%12.03 $111.70
2/13/20262,968,641 shares $330.11 million +0.6%31.3%4.94 $111.20
1/30/20262,952,346 shares $315.34 million -12.0%26.7%6.78 $106.81
1/15/20263,353,199 shares $352.22 million +6.5%29.4%8.4 $105.04
12/31/20253,148,062 shares $324.79 million +41.9%27.4%6.91 $103.17
12/15/20252,218,941 shares $227.75 million -1.4%17.9%5.27 $102.64
11/28/20252,249,767 shares $230.41 million +22.5%18.2%5.62 $102.42
11/14/20251,835,894 shares $181.50 million -13.8%14.8%4.24 $98.86
10/31/20252,130,021 shares $197.11 million -5.6%17.2%4.27 $92.54
10/15/20252,260,000 shares $208.21 million -21.0%16.9%4.2 $92.13
9/30/20252,860,000 shares $258.43 million +10.9%N/A5.3 $90.36
9/15/20252,580,000 shares $227.76 million +3.6%N/A6.8 $88.28
8/31/20252,490,000 shares $221.31 million No Change45.8%6.1 $88.88
2/15/20252,570,000 shares $225.88 million -9.8%41.2%9.9 $87.89
1/31/20252,850,000 shares $253.42 million -14.4%N/A11.6 $88.92
1/15/20253,330,000 shares $285.05 million +33.2%N/A15.1 $85.60
12/31/20242,500,000 shares $215.70 million -3.1%N/A12.9 $86.28
12/15/20242,580,000 shares $226.58 million -1.2%N/A13.7 $87.82
11/30/20242,610,000 shares $235.27 million +10.6%N/A14.1 $90.14
11/15/20242,360,000 shares $204.35 million +26.9%N/A12.1 $86.59
10/31/20241,860,000 shares $169.84 million +8.1%N/A11 $91.31
10/15/20241,720,000 shares $162.80 million -8.0%N/A11.6 $94.65
9/30/20241,870,000 shares $177.71 million -0.5%N/A12.8 $95.03
9/15/20241,880,000 shares $183.34 million -4.6%N/A13.9 $97.52
8/31/20241,970,000 shares $195.88 million +18.0%N/A14 $99.43
8/15/20241,670,000 shares $160.64 million -17.3%N/A11.8 $96.19
7/31/20242,020,000 shares $188.02 million +27.9%N/A14.8 $93.08
7/15/20241,580,000 shares $146.91 million +10.5%N/A10.8 $92.98
6/30/20241,430,000 shares $130.82 million +3.6%N/A9.7 $91.48
6/15/20241,380,000 shares $126.52 million -2.8%N/A9.2 $91.68
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
5/31/20241,420,000 shares $128.45 million +22.4%N/A9.5 $90.46
5/15/20241,160,000 shares $105.22 million -19.4%N/A8.2 $90.71
4/30/20241,440,000 shares $126.09 million +2.9%N/A9.5 $87.56
4/15/20241,400,000 shares $119.62 million -11.4%N/A11.3 $85.44
3/31/20248,700 shares $789.09 thousand -99.5%N/A0.1 $90.70
3/15/20241,570,000 shares $140.59 million -8.7%N/A13 $89.55
2/29/20241,720,000 shares $152.74 million +5.5%N/A14.9 $88.80
2/15/20241,630,000 shares $144.16 million -22.4%N/A14.9 $88.44
1/31/20242,100,000 shares $179.13 million -0.5%N/A18.6 $85.30
1/15/20242,110,000 shares $180.57 million +14.7%N/A19.3 $85.58
12/31/20231,840,000 shares $149.71 million -4.7%N/A16.5 $81.37
12/15/20231,930,000 shares $152.10 million -18.9%N/A18 $78.81
11/30/20232,380,000 shares $186.85 million -1.2%N/A21.7 $78.51
11/15/20232,410,000 shares $184.75 million +4.3%N/A20.9 $76.66
10/31/20232,310,000 shares $173.97 million +4.5%N/A18.7 $75.31
10/15/20232,210,000 shares $177.00 million -1.3%N/A17.3 $80.09
9/30/20232,240,000 shares $178.89 million -1.3%N/A17.2 $79.86
9/15/20232,270,000 shares $186.03 million -2.6%N/A16.7 $81.95
8/31/20232,330,000 shares $190.83 million +16.5%N/A17.2 $81.90
8/15/20232,000,000 shares $165.46 million -17.0%N/A15.6 $82.73
7/31/20232,410,000 shares $193.81 million -0.4%N/A19.2 $80.42
7/15/20232,420,000 shares $188.49 million +5.2%N/A20.7 $77.89
6/30/20232,300,000 shares $181.17 million +0.4%N/A20.1 $78.77
6/15/20232,290,000 shares $179.70 million +19.9%N/A21.6 $78.47
5/31/20231,910,000 shares $144.49 million -12.8%N/A16.6 $75.65
5/15/20232,190,000 shares $172.48 million -10.3%N/A16.7 $78.76
4/30/20232,440,000 shares $192.44 million +1.2%N/A17.7 $78.87
4/15/20232,410,000 shares $191.59 million +3.9%N/A14.3 $79.50
3/31/20232,320,000 shares $180.10 million +19.0%N/A14.4 $77.63
3/15/20231,950,000 shares $144.65 million -18.8%N/A12.1 $74.18
2/28/20232,400,000 shares $181.56 million +8.1%N/A15.1 $75.65
2/15/20232,220,000 shares $173.74 million -7.5%N/A15.4 $78.26
1/31/20232,400,000 shares $188.02 million -0.4%N/A16.8 $78.34
1/15/20232,410,000 shares $191.60 million +4.8%N/A17.1 $79.50
12/30/20222,300,000 shares $178.80 million -3.8%N/A18.4 $77.74
12/15/20222,390,000 shares $186.68 million +7.2%N/A16 $78.11
11/30/20222,230,000 shares $171.78 million +10.4%N/A14.5 $77.03
11/15/20222,020,000 shares $147.97 million +27.9%N/A12.5 $73.25
10/31/20221,580,000 shares $115.10 million +6.8%N/A10.1 $72.85
10/15/20221,480,000 shares $101.05 million No ChangeN/A8.8 $68.28
9/30/20222,150,000 shares $144.57 million +4.9%N/A13 $67.24
9/15/20222,050,000 shares $144.94 million -10.1%N/A13 $70.70
8/31/20222,280,000 shares $161.29 million +31.0%N/A12.7 $70.74
8/15/20221,740,000 shares $133.18 million +84.7%N/A9.3 $76.54
7/31/2022942,200 shares $72.46 million +45.4%N/A5 $76.90
7/15/2022648,000 shares $49.53 million +12.5%N/A3.8 $76.43
6/30/2022576,100 shares $44.27 million -3.0%N/A3.2 $76.84
6/15/2022593,600 shares $43.62 million +55.3%N/A3.4 $73.49
5/31/2022382,200 shares $30.28 million +1.7%N/A2.7 $79.23
5/15/2022375,700 shares $28.66 million +10.4%N/A3.1 $76.29
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
4/30/2022340,400 shares $26.40 million -5.6%N/A2.5 $77.55
4/15/2022360,400 shares $29.47 million +25.1%N/A2.7 $81.76
3/31/2022288,100 shares $22.98 million +3.3%N/A2.5 $79.76
3/15/2022279,000 shares $21.28 million +2.2%N/A2.9 $76.28
2/28/2022272,900 shares $20.66 million -6.0%N/A3.1 $75.71
2/15/2022290,300 shares $22.30 million +86.0%N/A3.5 $76.81
1/31/2022156,100 shares $11.84 million +14.7%N/A2.1 $75.85
1/15/2022136,100 shares $10.49 million -29.7%N/A3.1 $77.04
12/31/2021193,500 shares $14.89 million -12.0%N/A4.8 $76.96
12/15/2021219,900 shares $16.53 million +7.3%N/A6.2 $75.19
11/30/2021205,000 shares $14.64 million +0.5%N/A5.9 $71.43
11/15/2021203,900 shares $15.44 million -28.1%N/A6.1 $75.74
10/29/2021283,400 shares $21.30 million -5.6%N/A8.7 $75.15
10/15/2021300,200 shares $21.90 million +0.1%N/A8.8 $72.94
9/30/2021300,000 shares $21.85 million +19.2%N/A5.5 $72.82
9/15/2021251,600 shares $18.58 million +89.7%N/A4.9 $73.83
8/31/2021132,600 shares $10.08 million +2.7%N/A2.8 $76.04

PPH Short Interest - Frequently Asked Questions

Short interest is the volume of VanEck Pharmaceutical ETF shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 2,636,544 shares of PPH short. 31.24% of VanEck Pharmaceutical ETF's shares are currently sold short. Learn More on VanEck Pharmaceutical ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PPH shares currently have a short interest ratio of 12.1. Learn More on VanEck Pharmaceutical ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 31.24% of VanEck Pharmaceutical ETF's floating shares are currently sold short.

VanEck Pharmaceutical ETF saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 2,636,544 shares, a decline of 7.0% from the previous total of 2,834,538 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

31.24% of VanEck Pharmaceutical ETF's shares are currently sold short. Here is how the short interest of companies compare to VanEck Pharmaceutical ETF: First Trust Nasdaq Pharmaceuticals ETF (1.35%), VanEck Biotech ETF (1.09%), Invesco Dorsey Wright Healthcare Momentum ETF (1.74%), Invesco S&P SmallCap Health Care ETF (2.22%), F/m Emerald Life Sciences Innovation ETF (0.42%), and iShares Biotechnology ETF (20.45%).

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling PPH is an investing strategy that aims to generate trading profit from VanEck Pharmaceutical ETF as its price is falling. PPH shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for VanEck Pharmaceutical ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PPH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPH, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like PPH:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:PPH is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Central banks bought 710 tonnes - this fund pays monthly
Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Gold buyout deals have handed shareholders overnight gains up to 79 percent
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...
Golden Portfolio | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel
How a rare metal shortage sent gains up 2512 percent
In 2010, a rare earth metal called dysprosium surged 2,512 percent in two and a half years after China cut exp...
Awesomely | Sponsoredtc pixel
$100 for this… $500 for that. Here’s how to stop the bleeding today
Rising costs are squeezing households nationwide. USA Today reports more families are moving in together, whil...
Brownstone Research | Sponsoredtc pixel